Jonathan D Schofield, Yifen Liu, Prasanna Rao-Balakrishna, Rayaz A Malik, Handrean Soran. Diabetes Ther 2016
Times Cited: 132
Times Cited: 132
Times Cited
Times Co-cited
Similarity
10
IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045.
N H Cho, J E Shaw, S Karuranga, Y Huang, J D da Rocha Fernandes, A W Ohlrogge, B Malanda. Diabetes Res Clin Pract 2018
N H Cho, J E Shaw, S Karuranga, Y Huang, J D da Rocha Fernandes, A W Ohlrogge, B Malanda. Diabetes Res Clin Pract 2018
8
7
Clinical review 124: Diabetic dyslipidemia: causes and consequences.
I J Goldberg. J Clin Endocrinol Metab 2001
I J Goldberg. J Clin Endocrinol Metab 2001
7
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.
François Mach, Colin Baigent, Alberico L Catapano, Konstantinos C Koskinas, Manuela Casula, Lina Badimon, M John Chapman, Guy G De Backer, Victoria Delgado, Brian A Ference,[...]. Eur Heart J 2020
François Mach, Colin Baigent, Alberico L Catapano, Konstantinos C Koskinas, Manuela Casula, Lina Badimon, M John Chapman, Guy G De Backer, Victoria Delgado, Brian A Ference,[...]. Eur Heart J 2020
6
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.
W T Friedewald, R I Levy, D S Fredrickson. Clin Chem 1972
W T Friedewald, R I Levy, D S Fredrickson. Clin Chem 1972
5
Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017.
Thomas R Einarson, Annabel Acs, Craig Ludwig, Ulrik H Panton. Cardiovasc Diabetol 2018
Thomas R Einarson, Annabel Acs, Craig Ludwig, Ulrik H Panton. Cardiovasc Diabetol 2018
5
Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis.
P M Kearney, L Blackwell, R Collins, A Keech, J Simes, R Peto, J Armitage, C Baigent. Lancet 2008
P M Kearney, L Blackwell, R Collins, A Keech, J Simes, R Peto, J Armitage, C Baigent. Lancet 2008
5
Association between insulin resistance and the development of cardiovascular disease.
Valeska Ormazabal, Soumyalekshmi Nair, Omar Elfeky, Claudio Aguayo, Carlos Salomon, Felipe A Zuñiga. Cardiovasc Diabetol 2018
Valeska Ormazabal, Soumyalekshmi Nair, Omar Elfeky, Claudio Aguayo, Carlos Salomon, Felipe A Zuñiga. Cardiovasc Diabetol 2018
5
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
5
5
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.
Christopher P Cannon, Michael A Blazing, Robert P Giugliano, Amy McCagg, Jennifer A White, Pierre Theroux, Harald Darius, Basil S Lewis, Ton Oude Ophuis, J Wouter Jukema,[...]. N Engl J Med 2015
Christopher P Cannon, Michael A Blazing, Robert P Giugliano, Amy McCagg, Jennifer A White, Pierre Theroux, Harald Darius, Basil S Lewis, Ton Oude Ophuis, J Wouter Jukema,[...]. N Engl J Med 2015
5
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2019.
. Diabetes Care 2019
. Diabetes Care 2019
5
Dyslipidemia in type 2 diabetes: prevalence, pathophysiology, and management.
Joe M Chehade, Margaret Gladysz, Arshag D Mooradian. Drugs 2013
Joe M Chehade, Margaret Gladysz, Arshag D Mooradian. Drugs 2013
4
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies.
N Sarwar, P Gao, S R Kondapally Seshasai, R Gobin, S Kaptoge, E Di Angelantonio, E Ingelsson, D A Lawlor, E Selvin, M Stampfer,[...]. Lancet 2010
N Sarwar, P Gao, S R Kondapally Seshasai, R Gobin, S Kaptoge, E Di Angelantonio, E Ingelsson, D A Lawlor, E Selvin, M Stampfer,[...]. Lancet 2010
4
Metabolic origins and clinical significance of LDL heterogeneity.
Kaspar K Berneis, Ronald M Krauss. J Lipid Res 2002
Kaspar K Berneis, Ronald M Krauss. J Lipid Res 2002
4
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
Anushka Patel, Stephen MacMahon, John Chalmers, Bruce Neal, Laurent Billot, Mark Woodward, Michel Marre, Mark Cooper, Paul Glasziou, Diederick Grobbee,[...]. N Engl J Med 2008
Anushka Patel, Stephen MacMahon, John Chalmers, Bruce Neal, Laurent Billot, Mark Woodward, Michel Marre, Mark Cooper, Paul Glasziou, Diederick Grobbee,[...]. N Engl J Med 2008
4
Diabetes mellitus and oxidative stress-A concise review.
Ullah Asmat, Khan Abad, Khan Ismail. Saudi Pharm J 2016
Ullah Asmat, Khan Abad, Khan Ismail. Saudi Pharm J 2016
4
Effects of intensive glucose lowering in type 2 diabetes.
Hertzel C Gerstein, Michael E Miller, Robert P Byington, David C Goff, J Thomas Bigger, John B Buse, William C Cushman, Saul Genuth, Faramarz Ismail-Beigi, Richard H Grimm,[...]. N Engl J Med 2008
Hertzel C Gerstein, Michael E Miller, Robert P Byington, David C Goff, J Thomas Bigger, John B Buse, William C Cushman, Saul Genuth, Faramarz Ismail-Beigi, Richard H Grimm,[...]. N Engl J Med 2008
4
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R Poulter, Lasse S Ravn,[...]. N Engl J Med 2016
Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R Poulter, Lasse S Ravn,[...]. N Engl J Med 2016
4
Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition.
Pouya Saeedi, Inga Petersohn, Paraskevi Salpea, Belma Malanda, Suvi Karuranga, Nigel Unwin, Stephen Colagiuri, Leonor Guariguata, Ayesha A Motala, Katherine Ogurtsova,[...]. Diabetes Res Clin Pract 2019
Pouya Saeedi, Inga Petersohn, Paraskevi Salpea, Belma Malanda, Suvi Karuranga, Nigel Unwin, Stephen Colagiuri, Leonor Guariguata, Ayesha A Motala, Katherine Ogurtsova,[...]. Diabetes Res Clin Pract 2019
4
Global aetiology and epidemiology of type 2 diabetes mellitus and its complications.
Yan Zheng, Sylvia H Ley, Frank B Hu. Nat Rev Endocrinol 2018
Yan Zheng, Sylvia H Ley, Frank B Hu. Nat Rev Endocrinol 2018
4
Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms.
John R Petrie, Tomasz J Guzik, Rhian M Touyz. Can J Cardiol 2018
John R Petrie, Tomasz J Guzik, Rhian M Touyz. Can J Cardiol 2018
4
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.
D M Nathan, S Genuth, J Lachin, P Cleary, O Crofford, M Davis, L Rand, C Siebert. N Engl J Med 1993
D M Nathan, S Genuth, J Lachin, P Cleary, O Crofford, M Davis, L Rand, C Siebert. N Engl J Med 1993
3
Treatment of dyslipidemia in patients with type 2 diabetes.
Krishnaswami Vijayaraghavan. Lipids Health Dis 2010
Krishnaswami Vijayaraghavan. Lipids Health Dis 2010
5
Antidiabetic activity of Aloe vera L. juice. I. Clinical trial in new cases of diabetes mellitus.
S Yongchaiyudha, V Rungpitarangsi, N Bunyapraphatsara, O Chokechaijaroenporn. Phytomedicine 1996
S Yongchaiyudha, V Rungpitarangsi, N Bunyapraphatsara, O Chokechaijaroenporn. Phytomedicine 1996
4
Antidiabetic and antihyperlipidemic activities of Forsythia suspensa (Thunb.) Vahl (fruit) in streptozotocin-induced diabetes mice.
Yanyan Zhang, Fu Feng, Ting Chen, Zhongwen Li, Qingwu W Shen. J Ethnopharmacol 2016
Yanyan Zhang, Fu Feng, Ting Chen, Zhongwen Li, Qingwu W Shen. J Ethnopharmacol 2016
9
Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases.
Teresa Vanessa Fiorentino, Annamaria Prioletta, Pengou Zuo, Franco Folli. Curr Pharm Des 2013
Teresa Vanessa Fiorentino, Annamaria Prioletta, Pengou Zuo, Franco Folli. Curr Pharm Des 2013
3
Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose.
Ralph A DeFronzo, Muhammad Abdul-Ghani. Am J Cardiol 2011
Ralph A DeFronzo, Muhammad Abdul-Ghani. Am J Cardiol 2011
3
Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)
R C Turner, H Millns, H A Neil, I M Stratton, S E Manley, D R Matthews, R R Holman. BMJ 1998
R C Turner, H Millns, H A Neil, I M Stratton, S E Manley, D R Matthews, R R Holman. BMJ 1998
3
Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research.
Benjamin M Leon, Thomas M Maddox. World J Diabetes 2015
Benjamin M Leon, Thomas M Maddox. World J Diabetes 2015
3
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Steven P Marso, Stephen C Bain, Agostino Consoli, Freddy G Eliaschewitz, Esteban Jódar, Lawrence A Leiter, Ildiko Lingvay, Julio Rosenstock, Jochen Seufert, Mark L Warren,[...]. N Engl J Med 2016
Steven P Marso, Stephen C Bain, Agostino Consoli, Freddy G Eliaschewitz, Esteban Jódar, Lawrence A Leiter, Ildiko Lingvay, Julio Rosenstock, Jochen Seufert, Mark L Warren,[...]. N Engl J Med 2016
3
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
3
Prevalence and Risk Factors Associated with Dyslipidemia in Chongqing, China.
Li Qi, Xianbin Ding, Wenge Tang, Qin Li, Deqiang Mao, Yulin Wang. Int J Environ Res Public Health 2015
Li Qi, Xianbin Ding, Wenge Tang, Qin Li, Deqiang Mao, Yulin Wang. Int J Environ Res Public Health 2015
6
The prevalence of dyslipidemia in patients with diabetes mellitus of ayurveda Hospital.
Amit Kumar Dixit, Ranjit Dey, Aela Suresh, Siddhartha Chaudhuri, Ashok Kumar Panda, Achintya Mitra, Jayram Hazra. J Diabetes Metab Disord 2014
Amit Kumar Dixit, Ranjit Dey, Aela Suresh, Siddhartha Chaudhuri, Ashok Kumar Panda, Achintya Mitra, Jayram Hazra. J Diabetes Metab Disord 2014
14
Dyslipidemia in obesity: mechanisms and potential targets.
Boudewijn Klop, Jan Willem F Elte, Manuel Castro Cabezas. Nutrients 2013
Boudewijn Klop, Jan Willem F Elte, Manuel Castro Cabezas. Nutrients 2013
3
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.
Helen M Colhoun, D John Betteridge, Paul N Durrington, Graham A Hitman, H Andrew W Neil, Shona J Livingstone, Margaret J Thomason, Michael I Mackness, Valentine Charlton-Menys, John H Fuller. Lancet 2004
Helen M Colhoun, D John Betteridge, Paul N Durrington, Graham A Hitman, H Andrew W Neil, Shona J Livingstone, Margaret J Thomason, Michael I Mackness, Valentine Charlton-Menys, John H Fuller. Lancet 2004
3
Future perspectives of the pharmacological management of diabetic dyslipidemia.
Angelo Maria Patti, Rosaria Vincenza Giglio, Nikolaos Papanas, Manfredi Rizzo, Ali A Rizvi. Expert Rev Clin Pharmacol 2019
Angelo Maria Patti, Rosaria Vincenza Giglio, Nikolaos Papanas, Manfredi Rizzo, Ali A Rizvi. Expert Rev Clin Pharmacol 2019
25
Mechanism of Development of Atherosclerosis and Cardiovascular Disease in Diabetes Mellitus.
Naoto Katakami. J Atheroscler Thromb 2018
Naoto Katakami. J Atheroscler Thromb 2018
3
The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas.
T Szkudelski. Physiol Res 2001
T Szkudelski. Physiol Res 2001
3
The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions.
S H Downs, N Black. J Epidemiol Community Health 1998
S H Downs, N Black. J Epidemiol Community Health 1998
3
Prevalence of dyslipidemia among the diabetic patients in southern Bangladesh: A cross-sectional study.
Hrishov Das, Sujan Banik. Diabetes Metab Syndr 2019
Hrishov Das, Sujan Banik. Diabetes Metab Syndr 2019
50
New insights into the pathophysiology of dyslipidemia in type 2 diabetes.
Marja-Riitta Taskinen, Jan Borén. Atherosclerosis 2015
Marja-Riitta Taskinen, Jan Borén. Atherosclerosis 2015
3
10-year follow-up of intensive glucose control in type 2 diabetes.
Rury R Holman, Sanjoy K Paul, M Angelyn Bethel, David R Matthews, H Andrew W Neil. N Engl J Med 2008
Rury R Holman, Sanjoy K Paul, M Angelyn Bethel, David R Matthews, H Andrew W Neil. N Engl J Med 2008
3
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial.
A Keech, R J Simes, P Barter, J Best, R Scott, M R Taskinen, P Forder, A Pillai, T Davis, P Glasziou,[...]. Lancet 2005
A Keech, R J Simes, P Barter, J Best, R Scott, M R Taskinen, P Forder, A Pillai, T Davis, P Glasziou,[...]. Lancet 2005
3
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.